Month: February 2018

The Landscape for CROs post Brexit: An Update

UK still a key player The Clinical & Contract Research Association (CCRA) held a one-day session entitled The Landscape for CROs post Brexit—An Update on 31 January 2018 at the Royal Society of Medicine in London, one year on from a similar event in January 2017. The session was chaired by Dr Virginia Acha, Executive

Continue Reading

Spotlight on Cuba: How fostering business partnerships with Cuba could benefit the UK and global health industries

Recently, DWL met with a delegation from the Life Sciences sector in Cuba, as part of an initiative by the UK Department of International Trade. At the meeting were representatives from the Cuban Chamber of Commerce and other governmental bodies, as well as pharmaceutical and biotechnology agencies including BioCubaFarma, CECMED, CIGB and CIM-CIMAB. The aim

Continue Reading